Patents by Inventor Andreia C.K. MORTENSEN

Andreia C.K. MORTENSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of Excitatory Amino Acid Transporters and Methods Using Same
    Publication number: 20220267308
    Abstract: The present disclosure provides in one aspect compounds of Formula I. In certain embodiments, the compounds of the disclosure are useful for treating, ameliorating or preventing a disease or disorder that is caused, induced or characterized by abnormal reduction in glutamate transporter activity or abnormal increase in extracellular CNS glutamate concentration in a subject. In certain embodiments, the compounds of the disclosure stimulate a glutamate transporter.
    Type: Application
    Filed: July 17, 2020
    Publication date: August 25, 2022
    Inventors: Joseph M. Salvino, Andreia C.K. Mortensen, Valli Venkata Srikanth Yellamelli
  • Glutamate Transporter Activators and Methods Using Same
    Publication number: 20200255445
    Abstract: The present invention provides compounds useful for treating, ameliorating or preventing a disease or disorder that is caused, induced or characterized by abnormal reduction in glutamate transporter activity or abnormal increase in extracellular CNS glutamate concentration in a subject. In certain embodiments, the compound stimulates a glutamate transporter.
    Type: Application
    Filed: January 16, 2018
    Publication date: August 13, 2020
    Inventors: Sandhya Kortagere, Andreia C.K. Mortensen, Ole V. Mortensen, Joseph M. Salvino
  • NOVEL COMPOSITIONS USEFUL IN TREATING BRAIN-RELATED DISEASES OR DISORDERS AND METHODS USING SAME
    Publication number: 20160074408
    Abstract: The present invention provides compounds useful for treating or preventing a brain-related disease or disorder. The present invention further provides a method of treating or preventing a brain-related disease or disorder in a patient, the method comprising administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of modulating the activity of a monoamine transporter.
    Type: Application
    Filed: April 16, 2014
    Publication date: March 17, 2016
    Applicant: Drexel University
    Inventors: Sandhya KORTAGERE, Ole Valente MORTENSEN, Andreia C.K. MORTENSEN